Search results for Ki67

Anti-Ki67 antibody [MKI67/2462], Abcam, AB238019

Anti-Ki67 antibody [MKI67/2465], Abcam, AB238020

What is this antibody validated in? Anti-Ki67 antibody [MKI67/2465] (ab238020) is a mouse monoclonal antibody and is validated for use in Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P) in Human samples. Trusted by the scientific community Anti-Ki67 [MKI67/2465] (ab238020) was first used in a scientific publication in 2019 and has been cited over 10 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [MKI67/2465] also available for your convenience: ab238020, Biotin - ab271811

Anti-Ki67 antibody [SP6], prediluted, Abcam, AB21700

This product was switched from hybridoma to recombinant format on 25th October 2019. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Ki67/MKI67 Polyclonal Antibody, AntibodySystem, PHE46101

APC Anti-Ki67 antibody [EPR3610], Abcam, AB310886

What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

APC Anti-Ki67 antibody [SP6], Abcam, AB314285

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-Ki67/MKI67 Antibody (R3L43), AntibodySystem, RHE46102

Anti-Ki67/MKI67 Antibody (R3L44), AntibodySystem, RHE46103

Anti-Ki67/MKI67 Antibody (R3L45), AntibodySystem, RHE46104

Anti-Ki67/MKI67 Antibody (R3L46), AntibodySystem, RHE46101